Skip to main content
EMBO Molecular Medicine logoLink to EMBO Molecular Medicine
. 2024 Feb 5;16(3):665. doi: 10.1038/s44321-024-00030-4

Author Correction: Highly secreted tryptophanyl tRNA synthetase 1 as a potential theranostic target for hypercytokinemic severe sepsis

Yoon Tae Kim 1,#, Jin Won Huh 2,#, Yun Hui Choi 3, Hee Kyeong Yoon 3, Tram TT Nguyen 3, Eunho Chun 1, Geunyeol Jeong 1, Sunyoung Park 4, Sungwoo Ahn 5, Won-Kyu Lee 6, Young-Woock Noh 6, Kyoung Sun Lee 7, Hee-Sung Ahn 8, Cheolju Lee 9, Sang Min Lee 10, Kyung Su Kim 11, Gil Joon Suh 12, Kyeongman Jeon 13, Sunghoon Kim 14, Mirim Jin 1,3,4,15,
PMCID: PMC10940644  PMID: 38316935

Abstract

graphic file with name 44321_2024_30_Figa_HTML.jpg


Correction to: EMBO Molecular Medicine (2023) 16:40–63. 10.1038/s44321-023-00004-y | Published online 14 December 2023

There is an error in the Acknowledgements section of this article relating to a grant number for the Korea Health Technology R&D Project by the Korea Health Industry Development Institute (KHIDI) of the Ministry of Health & Welfare, Republic of Korea.

The Acknowledgements section is corrected from:

This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) of the Korean government (MSIT), Republic of Korea, grant numbers NRF-2019M3E5D5064771, the Korea Health Technology R&D Project by the Korea Health Industry Development Institute (KHIDI) of the Ministry of Health & Welfare, Republic of Korea, grant number HI20C0015, and HI122C10883, Daegu-Gyeongbuk/Osong Medical Cluster R&D Project funded by the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, Republic of Korea, grant number HI19C0763, and Korea Drug Development Fund funded by Ministry of Science and ICT, Ministry of Trade, Industry, and Energy, and Ministry of Health and Welfare, Republic of Korea, grant number RS-2022-00166575.

To (see changes in bold)

This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) of the Korean government (MSIT), Republic of Korea, grant numbers NRF-2019M3E5D5064771, the Korea Health Technology R&D Project by the Korea Health Industry Development Institute (KHIDI) of the Ministry of Health & Welfare, Republic of Korea, grant number HI20C0015, and HI22C1883, Daegu-Gyeongbuk/Osong Medical Cluster R&D Project funded by the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, Republic of Korea, grant number HI19C0763, and Korea Drug Development Fund funded by Ministry of Science and ICT, Ministry of Trade, Industry, and Energy, and Ministry of Health and Welfare, Republic of Korea, grant number RS-2022-00166575.

This change does not affect the text or interpretation of the article.


Articles from EMBO Molecular Medicine are provided here courtesy of Nature Publishing Group

RESOURCES